These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 37739730

  • 1. Efficacy of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine for the prevention of mucositis induced by platinum-based chemoradiation in head and neck cancer: A phase II study.
    Kuroki K, Rikimaru F, Kunitake N, Toh S, Higaki Y, Masuda M.
    Clin Nutr ESPEN; 2023 Oct; 57():730-734. PubMed ID: 37739730
    [Abstract] [Full Text] [Related]

  • 2. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
    Yokota T, Hamauchi S, Yoshida Y, Yurikusa T, Suzuki M, Yamashita A, Ogawa H, Onoe T, Mori K, Onitsuka T.
    Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
    [Abstract] [Full Text] [Related]

  • 3. Effect of HMB/Arg/Gln on the prevention of radiation dermatitis in head and neck cancer patients treated with concurrent chemoradiotherapy.
    Imai T, Matsuura K, Asada Y, Sagai S, Katagiri K, Ishida E, Saito D, Sadayasu R, Wada H, Saijo S.
    Jpn J Clin Oncol; 2014 May; 44(5):422-7. PubMed ID: 24688085
    [Abstract] [Full Text] [Related]

  • 4. Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine.
    May PE, Barber A, D'Olimpio JT, Hourihane A, Abumrad NN.
    Am J Surg; 2002 Apr; 183(4):471-9. PubMed ID: 11975938
    [Abstract] [Full Text] [Related]

  • 5. Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH).
    Pascoe J, Jackson A, Gaskell C, Gaunt C, Thompson J, Billingham L, Steven N.
    BMC Cancer; 2021 Jul 12; 21(1):800. PubMed ID: 34247580
    [Abstract] [Full Text] [Related]

  • 6. Perioperative Nutritional Support With Beta-hydroxy-beta-methylbutyrate, Arginine, and Glutamine in Surgery for Abdominal Malignancies.
    Wada N, Kurokawa Y, Tanaka K, Miyazaki Y, Makino T, Takahashi T, Wada H, Yamasaki M, Yamasaki M, Nakajima K, Eguchi H, Takiguchi S, Mori M, Doki Y.
    Wounds; 2018 Sep 12; 30(9):251-256. PubMed ID: 30256751
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122).
    Berk L, James J, Schwartz A, Hug E, Mahadevan A, Samuels M, Kachnic L, RTOG.
    Support Care Cancer; 2008 Oct 12; 16(10):1179-88. PubMed ID: 18293016
    [Abstract] [Full Text] [Related]

  • 8. Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study.
    Clark RH, Feleke G, Din M, Yasmin T, Singh G, Khan FA, Rathmacher JA.
    JPEN J Parenter Enteral Nutr; 2000 Oct 12; 24(3):133-9. PubMed ID: 10850936
    [Abstract] [Full Text] [Related]

  • 9. Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial.
    Marcora S, Lemmey A, Maddison P.
    Clin Nutr; 2005 Jun 12; 24(3):442-54. PubMed ID: 15896432
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the recovery after heart surgery following preoperative supplementation with a combination of beta-hydroxy-beta-methylbutyrate, L-arginine, and L-glutamine: a double-blind randomized placebo-controlled clinical trial.
    Norouzi M, Nadjarzadeh A, Maleki M, Khayyatzadeh SS, Hosseini S, Yaseri M, Fattahi H.
    Trials; 2022 Aug 13; 23(1):649. PubMed ID: 35964137
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of Perioperative Nutritional Therapy with the Glutamine/Arginine/Calcium β-Hydroxy-β-Methylbutyrate Product in Esophageal Cancer Surgery: A Single-Center Retrospective Study.
    Okamoto K, Takamura H, Nagayama T, Sannomiya Y, Hashimoto A, Nishiki H, Kaida D, Miyata T, Tsuji T, Fujita H, Kinami S, Ninomiya I, Inaki N.
    Nutrients; 2024 Jul 03; 16(13):. PubMed ID: 38999874
    [Abstract] [Full Text] [Related]

  • 12. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.
    Tsujimoto T, Yamamoto Y, Wasa M, Takenaka Y, Nakahara S, Takagi T, Tsugane M, Hayashi N, Maeda K, Inohara H, Uejima E, Ito T.
    Oncol Rep; 2015 Jan 03; 33(1):33-9. PubMed ID: 25351453
    [Abstract] [Full Text] [Related]

  • 13. Amelioration of radiation-induced acute inflammation and mucosal atrophy by beta-hydroxy-beta-methylbutyrate, L-glutamıne, and L-argınıne: results of an experimental study.
    Yavas C, Yavas G, Acar H, Toy H, Yuce D, Akyurek S, Ata O.
    Support Care Cancer; 2013 Mar 03; 21(3):883-8. PubMed ID: 22993027
    [Abstract] [Full Text] [Related]

  • 14. Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
    Hes C, Desilets A, Tonneau M, El Ouarzadi O, De Figueiredo Sousa M, Bahig H, Filion É, Nguyen-Tan PF, Christopoulos A, Benlaïfaoui M, Derosa L, Alves Costa Silva C, Ponce M, Malo J, Belkad W, Charpentier D, Aubin F, Hamilou Z, Jamal R, Messaoudene M, Soulières D, Routy B.
    Oral Oncol; 2024 Jan 03; 148():106623. PubMed ID: 38006691
    [Abstract] [Full Text] [Related]

  • 15. Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients.
    Kuhls DA, Rathmacher JA, Musngi MD, Frisch DA, Nielson J, Barber A, MacIntyre AD, Coates JE, Fildes JJ.
    J Trauma; 2007 Jan 03; 62(1):125-31; discussion 131-2. PubMed ID: 17215743
    [Abstract] [Full Text] [Related]

  • 16. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
    Gouvêa de Lima A, Villar RC, de Castro G, Antequera R, Gil E, Rosalmeida MC, Federico MH, Snitcovsky IM.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):270-5. PubMed ID: 21163585
    [Abstract] [Full Text] [Related]

  • 17. Supplementation with a combination of beta-hydroxy-beta-methylbutyrate (HMB), arginine, and glutamine is safe and could improve hematological parameters.
    Rathmacher JA, Nissen S, Panton L, Clark RH, Eubanks May P, Barber AE, D'Olimpio J, Abumrad NN.
    JPEN J Parenter Enteral Nutr; 2004 Jan 01; 28(2):65-75. PubMed ID: 15080599
    [Abstract] [Full Text] [Related]

  • 18. Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.
    Sakashita T, Homma A, Hatakeyama H, Furusawa J, Kano S, Mizumachi T, Iizuka S, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Fukuda S.
    Acta Otolaryngol; 2015 Aug 01; 135(8):853-8. PubMed ID: 25814008
    [Abstract] [Full Text] [Related]

  • 19. A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.
    Teknos TN, Grecula J, Agrawal A, Old MO, Ozer E, Carrau R, Kang S, Rocco J, Blakaj D, Diavolitsis V, Kumar B, Kumar P, Pan Q, Palettas M, Wei L, Baiocchi R, Savvides P.
    Invest New Drugs; 2019 Aug 01; 37(4):702-710. PubMed ID: 30569244
    [Abstract] [Full Text] [Related]

  • 20. A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
    Patil VM, Noronha V, Joshi A, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, Mahimkar M, Juvekar S, Arya S, Mahajan A, Agarwal A, Purandare N, Rangarajan V, Balaji A, Chaudhari SV, Banavali S, Kannan S, Bhattacharjee A, D'Cruz AK, Chaturvedi P, Pai PS, Chaukar D, Pantvaidya G, Nair D, Nair S, Deshmukh A, Thiagarajan S, Mathrudev V, Manjrekar A, Dhumal S, Maske K, Bhelekar AS, Nawale K, Chandrasekharan A, Pande N, Goel A, Talreja V, Simha V, Srinivas S, Swami R, Vallathol DH, Dsouza H, Shrirangwar S, Turkar S, Abraham G, Thanky AH, Patel U, Pandey MK, Prabhash K.
    Cancer; 2019 Sep 15; 125(18):3184-3197. PubMed ID: 31150120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.